0.5700USD+46.12%Mkt Cap: 7.67M USDP/E: —Last update: 2026-06-01
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap7.67M USD
Enterprise Value-16.59M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.86M USD
Revenue/Share—
Last Price0.5700 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.21
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.27
EPS (TTM)-3.33
EPS (Forward)-1.90
52W Range
0.26202% of range20.20
52W High20.20 USD
52W Low0.2620 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-229.71%
ROA-124.75%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.59M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-188.98%
Net Debt-21.96M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio3.85
Quick Ratio3.63
Book Value/Sh1.472 USD
Cash/Share1.693 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateMar 9, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)25.00 USD
Target Range5.000 USD – 40.00 USD
# Analysts3
Ownership
Shares Out.13.11M
Float11.38M
Insiders7.73%
Institutions27.72%
Short Interest
Short Ratio3.4d
Short % Float14.95%
Short % Out.14.57%
Shares Short1.87M
Short (prev mo.)1.83M
Technical
SMA 500.7252 (-21.4%)
SMA 2006.415 (-91.1%)
Beta0.75
S&P 52W Chg27.70%
Avg Vol (30d)734.37K
Avg Vol (10d)280.57K
Technical Indicators
RSI (14)28.8
MACD-0.1798
MACD Signal-0.2009
MACD Hist.+0.0211
BB Upper1.026 USD
BB Middle0.5729 USD
BB Lower0.1197 USD
BB Width158.22%
ATR (14)0.1095 USD
Vol Ratio (20d)0.05x